
Validea's guru fundamental report rates IQVIA Holdings (IQV) at 77% using Partha Mohanram's P/B Growth Investor model, which identifies low book-to-market stocks with characteristics for sustained future growth. While IQV, a large-cap biotech growth stock, passed most fundamental criteria including return on assets and cash flow, it failed on advertising and R&D to assets, positioning it just below the 80% threshold for strategic interest based on the model's parameters.
IQVIA Holdings Inc. (IQV) scores 77% on Validea's P/B Growth Investor model, which is based on the academic work of Partha Mohanram. This model specifically seeks to identify low book-to-market growth stocks with sustainable fundamentals. The 77% rating positions IQV as fundamentally sound but just below the 80% threshold that the strategy considers a level of interest. As a large-cap stock in the Biotechnology & Drugs industry, IQV passed the majority of the model's criteria, demonstrating strength in its book-to-market ratio, return on assets (ROA), cash flow from operations, and stability in both ROA and sales variance. However, the analysis flagged two specific weaknesses: the company failed the model's tests for Advertising to Assets and Research and Development to Assets. This suggests that while IQV exhibits strong operational and financial efficiency, its investment levels in key growth drivers like R&D and marketing may be considered low relative to its asset base by this particular quantitative screen.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment